Healthcare - Biotechnology - NASDAQ - US
$ 4.49
-7.8 %
$ 3.13 B
Market Cap
-5.41
P/E
BALANCE SHEET
504 M
ASSETS
1.09 B
LIABILITIES
-587 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
ImmunityBio, Inc.
| Current Assets | 294 M |
| Cash & Short-Term Investments | 266 M |
| Receivables | 3.17 M |
| Other Current Assets | 24.5 M |
| Non-Current Assets | 210 M |
| Long-Term Investments | 891 K |
| PP&E | 183 M |
| Other Non-Current Assets | 26.8 M |
| Current Liabilities | 58.3 M |
| Accounts Payable | 9.2 M |
| Short-Term Debt | 5.24 M |
| Other Current Liabilities | 43.8 M |
| Non-Current Liabilities | 1.03 B |
| Long-Term Debt | 721 M |
| Other Non-Current Liabilities | 311 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Cash & Cash Equivalents | 265.5 | 104.6 | 181.1 | 34.9 | 15.5 | 16.8 | 23.9 | 8.1 | 175.9 | 59.1 | 0.3 |
| Short Term Investments | 1.0 | 2.5 | 136.0 | 61.1 | 36.1 | 57.3 | 104.3 | 190.8 | 118.3 | 0 | 0 |
| Receivables | 3.2 | 1.9 | 1.3 | 0 | 0.3 | 12.2 | 1.3 | 0 | 1.8 | 0.1 | 0.4 |
| Inventory | 0 | 26.4 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Other Current Assets | 24.5 | 31.5 | 15.9 | 9.2 | 3.8 | 2.5 | 3.0 | 3.6 | 1.5 | 0.1 | 0.2 |
| Total Current Assets | 294.1 | 140.6 | 334.3 | 111.7 | 55.8 | 88.8 | 132.5 | 205.1 | 297.5 | 59.4 | 1.0 |
| PP&E | 182.7 | 189.4 | 119.2 | 90.7 | 72.2 | 76.9 | 76.7 | 19.3 | 6.1 | 0.2 | 13 K |
| Intangible Assets | 17.1 | 20.0 | 1.4 | 1.5 | 12.1 | 12.1 | 2.8 | 5.1 | 7.3 | 0.8 | 0.9 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0.9 | 5.7 | 6.8 | 10.4 | 10.9 | 14.4 | 38.3 | 87.8 | 55.1 | 0 | 0 |
| Other Long Term Assets | 9.7 | 6.6 | 7.2 | 3.3 | (11.1) | (1.7) | 0.2 | 0.1 | 0.3 | 0.4 | 0.2 |
| Other Assets | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 |
| Total Assets | 504.5 | 362.4 | 468.9 | 221.4 | 143.1 | 181.9 | 250.4 | 317.5 | 366.8 | 60.8 | 2.1 |
| LIABILITIES | |||||||||||
| Accounts Payable | 9.2 | 21.0 | 11.4 | 11.5 | 1.7 | 2.8 | 5.9 | 4.0 | 2.1 | 1.1 | 1.5 |
| Short Term Debt | 5.2 | 434.6 | 305.3 | 5.0 | 4.0 | 1.0 | 0.6 | 0.5 | (0.2) | 0.3 | 1.8 |
| Other Current Liabilities | 43.8 | 45.3 | 52.3 | 51.6 | 5.8 | 23.5 | 13.9 | 7.8 | 4.1 | 33 K | (1.2) |
| Total Current Liabilities | 58.3 | 500.9 | 369.0 | 68.1 | 11.6 | 27.3 | 20.9 | 12.6 | 6.1 | 2.4 | 5.0 |
| Long Term Debt | 721.5 | 289.2 | 380.5 | 270.5 | 21.8 | 5.9 | 6.7 | 7.7 | 4.9 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0.2 | 0.2 | 3.2 | 0 | 0.5 | 1.0 | 1.2 | 0 | 0 |
| Other Liabilities | 310.6 | 22.1 | (36.8) | 1.2 | (10.9) | 2.7 | 3.4 | 2.7 | (1.4) | 0.5 | 2.4 |
| Total Liabilities | 1 090.4 | 812.2 | 712.8 | 339.9 | 22.4 | 35.9 | 31.6 | 24.1 | 10.9 | 2.4 | 5.0 |
| EQUITY | |||||||||||
| Common Stock | 67 K | 42 K | 40 K | 38 K | 10 K | 8 K | 8 K | 8 K | 8 K | 3 K | 2 K |
| Retained Earnings | (2 961.7) | (2 378.5) | (1 961.9) | (1 615.1) | (662.2) | (595.0) | (498.7) | (387.1) | (250.4) | (12.7) | (6.5) |
| Other Accumulative Comprehensive Income/Loss | 10 K | 0.2 | 4 K | 0.1 | (0.1) | (0.3) | (0.4) | (0.3) | (0.2) | 46 K | 9 K |
| Total Equity | (585.9) | (449.8) | (243.9) | (118.5) | 124.3 | 133.7 | 218.8 | 293.4 | 356.0 | 58.4 | (2.9) |
| Total Liabilities and Equity | 504.5 | 362.4 | 468.9 | 221.4 | 143.1 | 181.9 | 250.4 | 317.5 | 366.8 | 60.8 | 2.1 |
| SHARES OUTSTANDING | |||||||||||
| Common Shares Outstanding | 508.6 | 399.9 | 389.2 | 383.2 | 383.2 | 79.1 | 80.6 | 82.0 | 71.5 | 315.7 | 0.8 |